Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes-MedSci.cn

Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes

Kong, FJ; Wu, JH; Sun, SY; Ma, LL; Zhou, JQ

Zhou, JQ (reprint author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.

NEUROPHARMACOLOGY, 2018; 131 (): 316

Abstract

Diabetic cognitive dysfunction has gained widespread attention for its deleterious impact on individuals with diabetes. However, few clinical interven......

Full Text Link